Monitor integration of Eaze operations in California, Florida, and Colorado, and watch for shareholder approval of CEO's performance-based equity awards. The Ace Ventures partnership may create near-term cash flow challenges due to the $16 million note structure.
Price Chart
Executive Summary
Vireo Growth Inc. completed its acquisition of Eaze Inc., issuing 90.4 million shares valued at $47 million, and simultaneously restructured its New York operations through a partnership with Ace Ventures. The company also amended its merger agreement and CEO's employment contract, including a potential $2.5 billion equity award contingent on performance milestones.
Key Financial Metrics
Key Facts
- Completed acquisition of Eaze Inc. by issuing 90,379,591 subordinate voting shares valued at $47,040,000
- Entered into partnership with Ace Venture of NY LLC for Vireo Health of New York, with Ace holding 51% ownership
- Amended CEO John Mazarakis's employment agreement with potential performance-based equity awards totaling up to 6% of fully diluted equity
- Issued $16 million promissory note from Vireo Health of New York to Vireo Health Inc. with 7% interest
- Appointed Michael Steiner to board of directors
Financial Impact
Diluted shareholders by issuing 90.4 million shares for Eaze acquisition and created $16 million intercompany note for New York operations
Risk Factors
- Integration risks from combining Eaze's operations
- Potential dilution from CEO's performance-based equity awards
- Cash flow timing mismatch in New York operations due to the $16 million note structure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-039924 |
| Document: tm2611166d1_ex10-2.htm | 0001104659-26-039924 |
| Document: tm2611166d1_ex2-2.htm | 0001104659-26-039924 |
| Document: tm2611166d1_ex99-2.htm | 0001104659-26-039924 |
| Document: tm2611166d1_ex99-1.htm | 0001104659-26-039924 |
| Document: 0001104659-26-039924-index-headers.html | 0001104659-26-039924 |
| Document: 0001104659-26-039924-index.html | 0001104659-26-039924 |
| Document: 0001104659-26-039924.txt | 0001104659-26-039924 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 18, 2026 6w ago | 8-K | $10.97 $12.11 | ▲ +10.39% | ▲ +11.91% | $9.61 (−12.40%) |
Aug 11, 2026 7w ago | 8-K | $10.64 $12.12 | ▲ +13.91% | ▲ +14.97% | $9.61 (−9.68%) |
Aug 5, 2026 8w ago | 8-K | $10.01 $10.84 | ▲ +8.29% | ▲ +7.69% | $9.61 (−4.00%) |
Jul 30, 2026 9w ago | 8-K | $9.44 $10.60 | ▲ +12.29% | ▲ +9.30% | $9.61 (+1.80%) |
Jul 27, 2026 9w ago | 8-K | $9.70 $10.89 | ▲ +12.27% | ▲ +8.97% | $9.61 (−0.93%) |
Jun 18, 2026 15w ago | 8-K | $10.42 $9.80 | ▼ −5.95% | ▼ −5.64% | $9.61 (−7.77%) |
Jun 11, 2026 16w ago | 8-K | $12.46 $10.02 | ▼ −19.58% | ▼ −20.84% | $9.61 (−22.87%) |
Jun 9, 2026 16w ago | 8-K | $12.90 $9.82 | ▼ −23.88% | ▼ −27.77% | $9.61 (−25.50%) |
May 29, 2026 18w ago | 8-K | $13.05 $9.99 | ▼ −23.47% | ▼ −22.17% | $9.61 (−26.34%) |
May 12, 2026 20w ago | 8-K | $12.09 $12.90 | ▼ −6.70% | ▼ −8.43% | $9.61 (+20.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access